Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-09-10 DOI:10.1080/21645515.2024.2397219

Emmanuel Marfo, Bukola Salami, Charles Adjei, Shannon MacDonald

引用次数: 0

Abstract

HPV vaccination is one of the safest and most effective interventions against HPV-related cancers. From 2013 to 2018, HPV vaccination was piloted in Ghana in preparation for a national program. Yet...

查看原文本刊更多论文

加纳私人资助项目中的人类乳头瘤病毒 (HPV) 疫苗接种：定性案例研究

接种HPV疫苗是预防HPV相关癌症最安全、最有效的干预措施之一。从2013年到2018年，HPV疫苗接种在加纳进行试点，为全国性计划做准备。然而...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.